1,193 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
ONCE Spark Therapeutics, Inc. $57.05 $2.14B N/A
Article Searches
Once More Unto The Breach https://seekingalpha.com/article/4252943-unto-breach?source=feed_all_articles Apr 05, 2019 - We are now just a stone's throw of breaching the old high of 2,930 on the S&P 500. The Bulls could achieve this tomorrow if they have the will to do so.The Bears will not go quietly into this good nig
Beverly Hills compound once owned by Cher and Eddie Murphy gets a big price chop http://www.latimes.com/business/realestate/hot-property/la-fi-hotprop-cher-eddie-murphy-beverly-hills-20190404-story.html Apr 04, 2019 -

In Beverly Hills, the price to live like Cher and Eddie Murphy is now about 44% cheaper.

An equestrian compound that counts both stars as former owners has returned to market at $48 million. That’s a considerable discount from when the five-acre estate first listed two years ago for $85 million....

With insulin price cap, drug industry is once again shamed into doing the right thing http://www.latimes.com/business/lazarus/la-fi-lazarus-insulin-drug-prices-20190404-story.html Apr 04, 2019 -

The United States doesn’t have a market-based economy for prescription drugs.

It has a shame-based economy.

The latest example of this Scarlet Letter approach to drug pricing came this week as insurance giant Cigna and its Express Scripts subsidiary announced that consumers with drug benefits managed...

The firm that once employed Trump’s pick to run Interior is making millions lobbying it https://www.washingtonpost.com/climate-environment/2019/04/03/firm-that-once-employed-trumps-pick-run-interior-is-making-millions-lobbying-it/ Apr 03, 2019 - Brownstein Hyatt Farber Schreck has quadrupled its business since David Bernhardt joined the Interior Department in 2017.
LNG will grow once U.S.-China trade tensions resolve, Cnooc VP says https://seekingalpha.com/news/3448285-lng-will-grow-u-s-china-trade-tensions-resolve-cnooc-vp-says?source=feed_news_all Apr 03, 2019 - Liquefied natural gas will become a big part of China-U.S. trade once tensions are resolved between the countries, a senior Cnooc (NYSE:CEO) VP Li Hui says at the LNG2019 conference in Shanghai.China
Yankees Plan C for ailing Troy Tulowitzki is prospect who was once shot http://www.nydailynews.com/sports/baseball/yankees/ny-sports-troy-tulowitzki-yankees-20190404-drlbj7csmnhvfckxqt6mbs4boy-story.html Apr 03, 2019 -

Before Miguel Andujar and Gleyber Torres joined the Baby Bombers wave, another infield prospect caught the Yankees’ intrigue.

Thairo Estrada was poised to battle for a starting job last season before a botched robbery in his hometown left a bullet in his right hip.

Over a year later, it seems he’s...

WPX Energy Monetizes Midstream Assets Once Again for $350M http://www.zacks.com/stock/news/370188/wpx-energy-monetizes-midstream-assets-once-again-for-%24350m?cid=CS-ZC-FT-370188 Apr 03, 2019 - WPX Energy's (WPX) subsidiary and joint venture partner in the Oryx II pipeline sign agreements to monetize its 25% interest in the Oryx II pipeline for $350 million.
Sangamo Rises on Positive Phase I/II Hemophilia Study Data http://www.zacks.com/stock/news/370133/sangamo-rises-on-positive-phase-i-ii-hemophilia-study-data?cid=CS-ZC-FT-370133 Apr 03, 2019 - Sangamo (SGMO) and partner Pfizer announce encouraging data from a phase I/II study evaluating their gene therapy candidate for treating hemophilia A.
Roche Extends Offer Period for Spark Therapeutics Acquisition http://www.zacks.com/stock/news/370066/roche-extends-offer-period-for-spark-therapeutics-acquisition?cid=CS-ZC-FT-370066 Apr 03, 2019 - Roche (RHHBY) withdraws its Premerger Notification and Report Form in connection with the pending acquisition of Spark Therapeutics.
Once Again, It's Time For These Leveraged ETFs http://feeds.benzinga.com/~r/benzinga/~3/D1OiaIQ6EZ4/once-again-its-time-for-these-leveraged-etfs Apr 03, 2019 -

The second quarter is still in its nascent stages, but that also means first-quarter earnings season will be soon arriving.

That also means investors will soon be treated to a deluge of earnings reports from the financial services sector.

read more

Pages: 1...56789101112131415...120

<<<Page 10>